Viriom
Boris Rogovoy has an extensive background in medicinal chemistry and discovery programs. Boris has held various leadership positions in prestigious companies such as Viriom Inc, DeepCure, Enamine Ltd., ChemSpace, Chromis Therapeutics, and ChemDiv, Inc. Prior to their industry experience, Boris has also worked as a scientist at Rutgers University, Center for Heterocyclic Compounds, and University of Florida. Boris obtained their PhD in Organic Chemistry from the University of Tartu.
This person is not in any offices
Viriom
Viriom is a commercial and late development stage biotech company developing novel therapies and prevention treatments against HIV and hepatitis B virus (HBV).